Autres langues DaVita Inc.

Actions

Marché Fermé - Nyse Autres places de cotation 22:00:02 03/05/2024			Varia. 5j.	Varia. 1 janv.
134,4 ^USD	-5,48 %		+0,70 %	+28,34 %

03/05	DAVITA INC. : UBS toujours positif	ZM
03/05	DAVITA INC. : Deutsche Bank Securities reste à l'achat	ZM

DaVita gains after upbeat quarterly profit prompts annual forecast raise	02/05
DaVita Q1 Adjusted Earnings, Revenue Rise; 2024 EPS Guidance Range Narrows; Shares Gain After Hours	02/05
Earnings Flash (DVA) DAVITA Reports Q1 EPS $2.38, vs. Street Est of $1.89	02/05
Earnings Flash (DVA) DAVITA Reports Q1 Revenue $3.07B, vs. Street Est of $3.02B	02/05
DaVita Inc. 1st Quarter 2024 Results	02/05
DaVita Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05
DaVita Inc. announces an Equity Buyback.	01/05
DaVita Inc. authorizes a Buyback Plan.	30/04
DaVita Inc. Announces Designing and Opening the First All-Electric Net-Zero Dialysis Center in the U.S, Powered by Solar Energy	22/04
DaVita Inc. Schedules 1st Quarter 2024 Investor Conference Call	18/04
DaVita Announces Dennis Pullin to its Board of Directors	10/04
Davita Announces Dennis Pullin to Its Board of Directors	10/04
DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2024	11/03
DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2024	08/03
Sector Update: Health Care Stocks Retreating Late Afternoon	05/03
Sector Update: Health Care Stocks Lower Tuesday Afternoon	05/03
Fresenius Medical Care to Sell Dialysis Clinics in Brazil, Colombia, Chile, Ecuador to DaVita	05/03
Dialysis providers gain as investors focus on cardiac benefits after Ozempic's latest data	05/03
FMC verkauft Dialysekliniken in Südamerika mit Verlust	05/03
Dialysis firms gain as Ozempic kidney trial data disappoints	05/03

Aucun résultat pour cette recherche